Weight control, endocrine hormones and cancer prevention

Experimental Biology and Medicine

Volumn 238, Issue 5, 2013, Pages 502-508

  King, Brenee ^a   Jiang, Yu ^a   Su, Xiaoyu ^a   Xu, Jianteng ^a   Xie, Linglin ^a   Standard, Joseph ^a   Wang, Weiqun ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

Cancer prevention; Dietary calorie restriction; Glucocorticoids; IGF 1; Leptin; Physical activity; Weight control

Indexed keywords

GLUCOSE TRANSPORTER 4; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

APOPTOSIS; CALORIC RESTRICTION; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; DISEASE ASSOCIATION; ENDOCRINE FUNCTION; ENERGY BALANCE; EXERCISE; GENETIC TRANSCRIPTION; HUMAN; INSULIN BLOOD LEVEL; NONHUMAN; OBESITY; ONCOGENE RAS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; WEIGHT CONTROL;

CANCER PREVENTION; DIETARY CALORIE RESTRICTION; GLUCOCORTICOIDS; IGF-1; LEPTIN; PHYSICAL ACTIVITY; WEIGHT CONTROL;

ADIPONECTIN; ANIMALS; CALORIC RESTRICTION; GLUCOCORTICOIDS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; NEOPLASMS; OBESITY; PREVALENCE; WEIGHT LOSS;

EID: 84881594817     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213480695     Document Type: Review

References (86)

1. Grabner M. BMI trends, socioeconomic status, and the choice of dataset. Obes Facts 2012;5:112-126
2. Wang W. Editorial: weight control, endocrine hormones, and cancer prevention. J Nutr Food Sci 2012;2:e107
3. Calle EE, Roriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003;348:1625-1638
4. Hall KD, Heymsfield SB, Kemnitz JW, Klein S, Schoeller DA, Speakman JR. Energy balance and its components: implications for body weight regulation. Am J Clin Nutr 2012;95:989-994
5. Moreschi CZ. Beziehungen zwischen ernahrung und tumorwachstum. Immunitatsforsch 1909;2:651-675
6. Kritchevsky D. Caloric restriction and experimental carcinogenesis. Adv Exp Med Biol 1992;322:131-141
7. Vainio H, Kaaks R, Bianchini F. Weight control and physical activity in cancer prevention: international evaluation of the evidence. Eur J Cancer Prev 2002;2:S94-S100
8. Patel AV, Feigelson HS, Talbot JT, McCullough ML, Rodriguez C, Patel RC, Thun MJ, Calle EE. The role of body weight in the relationship between physical activity and endometrial cancer: results from a large cohort of US women. Int J Cancer 2008;123:1877-8182
9. Inoue M, Yamamoto S, Kurahashi N, Iwasaki M, Sasazuki S, Tsugane S. Japan public health center-based prospective study group. Daily total physical activity level and total cancer risk in men and women: results from a large-scale population-based cohort study in Japan. Am J Epidemiol 2008;168:391-403
10. Friedenreich CM, Orenstein MR. Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 2002;132:3456S-3464S
11. Hoffman-Goetz L. Physical activity and cancer prevention: animaltumor models. Med Sci Sports Exerc 2003;35:1828-1833
12. Davis JM, Kohut ML, Jackson DA, Colbert LH, Mayer EP, Ghaffar A. Exercise effects on lung tumor metastases and in vitro alveolar macrophage antitumor cytotoxicity. Am J Physiol 1998;274:R1454-R1459
13. Hoffman-Goetz L, May KM, Arumugam Y. Exercise training and mouse mammary tumour metastasis. Anticancer Res 1994;14:2627-2631
14. Radak Z, Gaal D, Taylor AW, Kaneko T, Tahara S, Nakamoto H, Goto S. Attenuation of the development of murine solid leukemia tumor by physical exercise. Antioxid Redox Signal 2002;4:213-219
15. Xie L, Jiang Y, Ouyang P, Chen J, Doan H, Herndon B, Sylvester JE, Zhang K, Molteni A, Reichle M, Zhang R, Haub MD, Baybutt RC, Wang W. Effects of dietary calorie restriction or exercise on the PI3K and Ras signaling pathways in the skin of mice. J Biol Chem 2007;282:28025-28035
16. Moore T, Carbajal S, Beltran L, Perkins SN, Yakar S, Leroith D, Hursting SD, Digiovanni J. Reduced susceptibility to two-stage skin carcinogenesis in mice with low circulating insulin-like growth factor I levels. Cancer Res 2008;68:3680-3688
17. Koerner A, Kratzsch J, Kiess W. Adipocytokines: leptin-the classical, resistin-the controversical, adiponectin-the promising, and more to come. Best Pract Res Clin Endocrinol Metab 2005;19:525-546
18. Stewart JW, Koehler K, Jackson W, Hawley J, Wang W, Au A, Myers R, Birt DF. Prevention of mouse skin tumor promotion by dietary energy restriction requires an intact adrenal gland and glucocorticoid supplementation restores inhibition. Carcinogenesis 2005;26:1077-1084
19. Jiang Y, Wang W. Potential mechanisms of cancer prevention by weight control. Biophys Rev Lett 2008;3:421-437
20. Kaaks R. Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence. Novartis Found Symp 2004;262:247-260
21. Weroha SJ, Haluska P. The insulin-like growth factor system in cancer. Endocrinol Metab Clin North Am 2012;41:335-350
22. Sureshbabu A, Tonner E, Flint DJ. Insulin-like growth factor binding proteins and mammary gland development. Int J Dev Biol 2011;55:781-789
23. Kurmasheva RT, Houghton PJ. IGF-I mediated survival pathways in normal and malignant cells. Biochim Biophys Acta 2006;1766:1-22
24. DeLellis K, Rinaldi S, Kaaks RJ, Kolonel LN, Henderson B, Le Marchand L. Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2004;13:1444-1451
25. Zhao H, Grossman HB, Spitz MR, Lerner SP, Zhang K, Wu X. Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol 2003;169:714-717
26. Chen C, Lewis SK, Voigt L, Fitzpatrick A, Plymate SR, Weiss NS. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin. Cancer 2005;103:76-84
27. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 2008;8:915-928
28. Eckstein N, Servan K, Hildebrandt B, Politz A, von Jonquieres G, Wolf- Kummeth S, Napierski I, Hamacher A, Kassack MU, Budczies J, Beier M, Dietel M, Royer-Pokora B, Denkert C, Royer HD. Hyperactivation of the insulin-like growth factor receptor I signaling pathway is an essential event for cisplatin resistance of ovarian cancer cells. Cancer Res 2009;69:2996-3003
29. Cao H, Wang G, Meng L, Shen H, Feng Z, Liu Q, Du J. Association between Circulating Levels of IGF-1 and IGFBP-3 and lung cancer risk: a meta-analysis. PLoS One 2012;7:e49884
30. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001;131:3109S-3120S
31. Bol DK, Kiguchi K, Gimenez-Conti I, Rupp T, DiGiovanni J. Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice. Oncogene 1997;14:1725-1734
32. DiGiovanni J, Bol DK, Wilker E, Beltran L, Carbajal S, Moats S, Ramirez A, Jorcano J, Kiguchi K. Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion. Cancer Res 2000;60:1561-1570
33. Wilker E, Lu J, Rho O, Carbajal S, Beltran L, DiGiovanni J. Role of PI3K/ Akt signaling in insulin-like growth factor-1 (IGF-1) skin tumor promotion. Mol Carcinog 2005;44:137-145
34. Jiang Y, Ma H, Su X, Chen J, Xu J, Standard J, Lin D, Wang W. IGF-1 mediates exercise-induced phospholipid alteration in the murine skin tissues. J Nutr Food Sci 2012:S2-S003
35. Ruggeri BA, Klurfeld DM, Kritchevsky D, Furlanetto RW. Caloric restriction and 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in rats: alterations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor. Cancer Res 1989;49:4130-4134
36. Ouyang P, Jiang Y, Doan HM, Xie L, Vasquez D, Welti R, Su X, Lu N, Herndon B, Yang SS, Jeannotte R, Wang W. Weight Loss via exercise with controlled dietary intake may affect phospholipid profile for cancer prevention in murine skin tissues. Cancer Prev Res (Phila) 2010;3:466-477
37. Xie L, Wang W. Weight control and cancer Prevention: role of IGF-1- mediated signaling pathways. Exp Biol Med 2013;238:127-132
38. Fontana L, Klein S, Holloszy JO. Long-term low-protein, low-calorie diet and endurance exercise modulate metabolic factors associated with cancer risk. Am J Clin Nutr 2006;84:1456-1462
39. Hursting SD, Digiovanni J, Dannenberg AJ, Azrad M, Leroith D, Demark-Wahnefried W, Kakarala M, Brodie A, Berger NA. Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev Res (Phila) 2012;5:1260-1272
40. Fruhbeck G, Jebb SA, Prentice AM. Leptin: physiology and pathophysiology. Clin Physiol 1998;18:399-419
41. Fruhbeck G. A heliocentric view of leptin. Proc Nutr Soc 2001;60:301-318
42. Unger RH. The hyperleptinemia of obesity-regulator of caloric surpluses. Cell 2004;117:145-146
43. Ahima RS, Flier JS. Leptin. Annu Rev Physiol 2000;62:413-437
44. Fruhbeck G. Peripheral actions of leptin and its involvement in disease. Nutr Rev 2002;60:S47-55; discussion S68-84
45. Bjorbaek C, Kahn BB. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 2004;59:305-331
46. Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol 2006;207:12-22
47. Fruhbeck G. Intracellular signalling pathways activated by leptin. Biochem J 2006;393:7-20
48. Frankenberry KA, Skinner H, Somasundar P, McFadden DW, Vona- Davis LC. Leptin receptor expression and cell signaling in breast cancer. Int J Oncol 2006;28:985-993
49. Sulkowska M, Golaszewska J, Wincewicz A, Koda M, Baltaziak M, Sulkowski S. Leptin-from regulation of fat metabolism to stimulation of breast cancer growth. Pathol Oncol Res 2006;12:69-72
50. Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP. Leptin is a growth factor for colonic epithelial cells. Gastroenterology 2001;121:79-90
51. Liu Z, Uesaka T, Watanabe H, Kato N. High fat diet enhances colonic cell proliferation and carcinogenesis in rats by elevating serum leptin. Int J Oncol 2001;19:1009-1014
52. Housa D, Housova J, Vernerova Z, Haluzik M. Adipocytokines and cancer. Physiol Res 2006;55:233-244
53. Ishigaki T, Koyama K, Tsujita J, Tanaka N, Hori S, Oku Y. Plasma leptin levels of elite endurance runners after heavy endurance training. J Physiol Anthropol Appl Human Sci 2005;24:573-578
54. Finlayson CA, Chappell J, Leitner JW, Goalstone ML, Garrity M, Nawaz S, Ciaraldi TP, Draznin B. Enhanced insulin signaling via Shc in human breast cancer. Metabolism 2003;52:1606-1611
55. Powell DR, Suwanichkul A, Cubbage ML, DePaolis LA, Snuggs MB, Lee PD. Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1. J Biol Chem 1991;266:18868-18876
56. Underwood LE, Thissen JP, Lemozy S, Ketelslegers JM, Clemmons DR. Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm Res 1994;42:145-151
57. Bjork J, Nilsson J, Hultcrantz R, Johansson C. Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. Scand J Gastroenterol 1993;28:879-884
58. Pandini G, Vigneri R, Costantino A, Frasca F, Ippolito A, Fujita- Yamaguchi Y, Siddle K, Goldfine ID, Belfiore A. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Clin Cancer Res 1999;5:1935-1944
59. Arcidiacono B, Iiritano S, Nocera A, Possidente K, Nevolo MT, Ventura V, Foti D, Chiefari E, Brunetti A. Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res 2012;2012:789174
60. Zhu Z, Jiang W, McGinley J, Wolfe P, Thompson HJ. Effects of dietary energy repletion and IGF-1 infusion on the inhibition of mammary carcinogenesis by dietary energy restriction. Mol Carcinog 2005;42:170-176
61. Paz-Filho G, Lim EL, Wong ML, Licinio J. Associations between adipokines and obesity-related cancer. Front Biosci 2011;16:1634-1650
62. Shehzad A, Iqbal W, Shehzad O, Lee Y. Adiponectin: regulation of its production and its role in human diseases. Hormones 2012;11:8-20
63. Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo FC, Fu OY, Chen HY, Hou MF, Yuan SS. Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 2006;237:109-114
64. Kang JH, Lee YY, Yu BY, Yang BS, Cho KH, Yoon DK, Roh YK. Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch Pharm Res 2005;28:1263-1269
65. Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, Bedir S. Prostate cancer and adiponectin. Urology 2005;65:1168-72
66. Ishikawa M, Kitayama J, Kazama S, Hiramatsu T, Hatano K, Nagawa H. Plasma adiponectin and gastric cancer. Clin Cancer Res 2005;11:466-472
67. Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005;97:1688-1694
68. Zhu M, Miura J, Lu LX, Bernier M, DeCabo R, Lane MA, Roth GS, Ingram DK. Circulating adiponectin levels increase in rats on caloric restriction: the potential for insulin sensitization. Exp Gerontol 2004;39:1049-1059
69. Barnholt KE, Hoffman AR, Rock PB, Muza SR, Fulco CS, Braun B, Holloway L, Mazzeo RS, Cymerman A, Friedlander AL. Endocrine responses to acute and chronic high-altitude exposure (4,300 meters): modulating effects of caloric restriction. Am J Physiol Endocrinol Metab 2006;290:E1078-E1088
70. Jamurtas AZ, Theocharis V, Koukoulis G, Stakias N, Fatouros IG, Kouretas D, Koutedakis Y. The effects of acute exercise on serum adiponectin and resistin levels and their relation to insulin sensitivity in overweight males. Eur J Appl Physiol 2006;97:122-126
71. Oberbach A, Tonjes A, Kloting N, Fasshauer M, Kratzsch J, Busse MW, Paschke R, Stumvoll M, Bluher M. Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol 2006;154:577-585
72. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Tenner AJ, Tomiyama Y, Matsuzawa Y. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth ofmyelomonocytic progenitors and the functions of macrophages. Blood 2000;96:1723-1732
73. Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y, Pecquery R. Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 2006;345:271-279
74. Zhu Z, Jiang W, Zacher JH, Neil ES, McGinley JN, Thompson HJ. Effects of energy restriction and wheel running on mammary carcinogenesis and host systemic factors in a rat model. Cancer Prev Res (Phila) 2012;5:414-422
75. So AY, Chaivorapol C, Bolton EC, Li H, Yamamoto KR. Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet 2007;3:e94
76. John S, Johnson TA, Sung MH, Biddie SC, Trump S, Koch-Paiz CA, Davis SR, Walker R, Meltzer PS, Hager GL. Kinetic complexity of the global response to glucocorticoid receptor action. Endocrinology 2009;150:1766-1774
77. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 1990;249:1266-1272
78. Stocklin E, Wissler M, Gouilleux F, Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 1996;383:726-728
79. Subramaniam N, Campion J, Rafter I, Okret S. Cross-talk between glucocorticoid and retinoic acid signals involving glucocorticoid receptor interaction with the homoeodomain protein Pbx1. Biochem J 2003;370:1087-1095
80. Gursoy E, Cardounel A, Hu Y, Kalimi M. Biological effects of long-term caloric restriction: adaptation with simultaneous administration of caloric stress plus repeated immobilization stress in rats. Exp Biol Med 2001;226:97-102
81. Birt DF, Yaktine A, Duysen E. Glucocorticoid mediation of dietary energy restriction inhibition of mouse skin. Carcinogenesis. J Nutr 1999;129:571S-574S
82. Zhu Z, Jiang W, Thompson HJ. Effect of corticosterone administration on mammary gland development and p27 expression and their relationship to the effects of energy restriction onmammary carcinogenesis. Carcinogenesis 1998;19:2101-2106
83. Zhu Z, Jiang W, Thompson HJ. Mechanisms by which energy restriction inhibits rat mammary carcinogenesis: in vivo effects of corticosterone on cell cycle machinery in mammary carcinomas. Carcinogenesis 2003;24:1225-1231
84. Pashko LL, Schwartz AG. Reversal of food restriction-induced inhibition of mouse skin tumor promotion by adrenalectomy. Carcinogenesis 1992;13:1925-1928
85. Pashko LL, Schwartz AG. Inhibition of 7,12-dimethylbenz[a]anthracene- induced lung tumorigenesis in A/J mice by food restriction is reversed by adrenalectomy. Carcinogenesis 1996;17:209-212
86. Zhu Z, Jiang W, Thompson HJ. An experimental paradigm for studying the cellular and molecular mechanisms of cancer inhibition by energy restriction. Mol Carcinogen 2002;35:51-56